OBJECTIVE: The purpose of this study was to examine differences in novel markers of cardiovascular disease (CVD) in women with type 2 diabetes stratified according to cardiorespiratory fitness. RESEARCH DESIGN AND METHODS: A total of 28 women (mean age 57 +/- 6 years) with type 2 diabetes who were free from overt CVD were placed into low cardiorespiratory fitness (LCF) or average cardiorespiratory fitness (ACF) groups based on a graded exercise test to exhaustion. A group of eight women without type 2 diabetes were also examined and served as healthy control subjects. The median VO(2peak) value was used as a cutoff for group determination. We assessed both conventional CVD risk factors, including blood pressure, BMI, and lipid profile, as well as novel CVD risk factors, such as left ventricular filling dynamics, arterial stiffness, fasting insulin, and C-reactive protein (CRP). RESULTS: VO(2peak) values were 69 +/- 14 and 91 +/- 24% of predicted values for sedentary age-matched healthy individuals in the LCF and ACF groups, respectively. BMI was significantly greater in the LCF group (P < 0.05); however, no differences were observed in age, lipid profile, or resting hemodynamics. CRP was 3.3-fold higher in the LCF group (6.3 +/- 41. vs. 1.9 +/- 1.7 mg/l, P < 0.05), whereas other novel markers of CVD were not significantly different between the groups. Significant negative relationships were observed between VO(2peak) and both CRP (r = -0.49) and the homeostasis model assessment index (r = -0.48) (P < 0.05). CONCLUSIONS: The novel finding of this investigation is that low cardiorespiratory fitness is associated with elevated CRP and reduced fasting glucose control in women with type 2 diabetes.
OBJECTIVE: The purpose of this study was to examine differences in novel markers of cardiovascular disease (CVD) in women with type 2 diabetes stratified according to cardiorespiratory fitness. RESEARCH DESIGN AND METHODS: A total of 28 women (mean age 57 +/- 6 years) with type 2 diabetes who were free from overt CVD were placed into low cardiorespiratory fitness (LCF) or average cardiorespiratory fitness (ACF) groups based on a graded exercise test to exhaustion. A group of eight women without type 2 diabetes were also examined and served as healthy control subjects. The median VO(2peak) value was used as a cutoff for group determination. We assessed both conventional CVD risk factors, including blood pressure, BMI, and lipid profile, as well as novel CVD risk factors, such as left ventricular filling dynamics, arterial stiffness, fasting insulin, and C-reactive protein (CRP). RESULTS: VO(2peak) values were 69 +/- 14 and 91 +/- 24% of predicted values for sedentary age-matched healthy individuals in the LCF and ACF groups, respectively. BMI was significantly greater in the LCF group (P < 0.05); however, no differences were observed in age, lipid profile, or resting hemodynamics. CRP was 3.3-fold higher in the LCF group (6.3 +/- 41. vs. 1.9 +/- 1.7 mg/l, P < 0.05), whereas other novel markers of CVD were not significantly different between the groups. Significant negative relationships were observed between VO(2peak) and both CRP (r = -0.49) and the homeostasis model assessment index (r = -0.48) (P < 0.05). CONCLUSIONS: The novel finding of this investigation is that low cardiorespiratory fitness is associated with elevated CRP and reduced fasting glucose control in women with type 2 diabetes.
Authors: C O Francisco; A M Catai; S C G Moura-Tonello; S L B Lopes; B G Benze; A M Del Vale; A M O Leal Journal: Braz J Med Biol Res Date: 2014-05-02 Impact factor: 2.590
Authors: Andrew M Wilson; Amir H Sadrzadeh-Rafie; Jonathan Myers; Themistocles Assimes; Kevin T Nead; Mamie Higgins; Andre Gabriel; Jeffrey Olin; John P Cooke Journal: J Vasc Surg Date: 2011-06-12 Impact factor: 4.268
Authors: Damon L Swift; Neil M Johannsen; Conrad P Earnest; Steven N Blair; Timothy S Church Journal: Med Sci Sports Exerc Date: 2012-06 Impact factor: 5.411
Authors: Kristin L Campbell; Peter T Campbell; Cornelia M Ulrich; Mark Wener; Catherine M Alfano; Karen Foster-Schubert; Rebecca E Rudolph; John D Potter; Anne McTiernan Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Brandy A Wicklow; Kristy D M Wittmeier; Andrea C MacIntosh; Elizabeth A C Sellers; Lawrence Ryner; Hacene Serrai; Heather J Dean; Jonathan M McGavock Journal: Diabetes Care Date: 2012-02-22 Impact factor: 19.112
Authors: Jonathan McGavock; Sandra Mandic; Richard Lewanczuk; Matthew Koller; Isabelle Vonder Muhll; Arthur Quinney; Dylan Taylor; Robert Welsh; Mark Haykowsky Journal: Cardiovasc Diabetol Date: 2004-03-15 Impact factor: 9.951